Antitumor activity of TY-011 against gastric cancer by inhibiting Aurora A, Aurora B and VEGFR2 kinases

被引：0
|
作者：
Wang Liu
Yu Lu
Xiaoping Chai
Xiao Liu
Tong Zhu
Xihan Wu
Yanfen Fang
Xuan Liu
Xiongwen Zhang
机构：
[1] East China Normal University,Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development, School of Chemistry and Molecular Engineering
[2] Nanjing Tianyi Bioscience Co. Ltd,Department of Cardiology, Shanghai Renji Hospital, School of Medicine
[3] Shanghai Jiaotong University,School of Physics and Materials Science
[4] East China Normal University,undefined
来源：
Journal of Experimental & Clinical Cancer Research | / 35卷
关键词：
Gastric cancer; Cell cycle; Angiogenesis; Polyploidy; Apoptosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Antitumor activity of TY-011 against gastric cancer by inhibiting Aurora A, Aurora B and VEGFR2 kinases
    Liu, Wang
    Lu, Yu
    Chai, Xiaoping
    Liu, Xiao
    Zhu, Tong
    Wu, Xihan
    Fang, Yanfen
    Liu, Xuan
    Zhang, Xiongwen
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2016, 35 : 1 - 15
  • [2] Antitumor activity of a novel Aurora A/B kinases inhibitor TY-011 against gastric cancer by inducing DNA damage
    Jiang Tongtong
    Liu Wang
    Lu Yu
    Fang Yanfen
    Chen Rui
    Zhang Wanli
    Liu Xuan
    Zhang Xiongwen
    ANTI-CANCER DRUGS, 2020, 31 (05) : 440 - 451
  • [3] Antitumor Activity of KW-2450 against Triple-Negative Breast Cancer by Inhibiting Aurora A and B Kinases
    Kai, Kazuharu
    Kondo, Kimie
    Wang, Xiaoping
    Xie, Xuemei
    Pitner, Mary K.
    Reyes, Monica E.
    Torres-Adorno, Angie M.
    Masuda, Hiroko
    Hortobagyi, Gabriel N.
    Bartholomeusz, Chandra
    Saya, Hideyuki
    Tripathy, Debu
    Sen, Subrata
    Ueno, Naoto T.
    MOLECULAR CANCER THERAPEUTICS, 2015, 14 (12) : 2687 - 2699
  • [4] In vitro and vivo anticancer activities of dual inhibitors of Aurora kinases and VEGFR2
    Fang, Li
    Sho, Angela
    Eng, Stacey L.
    Hsu, Nancy
    Aurrecoechea, Natalia
    Robinson, Louise
    Simon, Reyna J.
    Cheng, Mingshan
    Cai, Danying
    Keck, James G.
    Sambucetti, Lidia
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3594S - 3594S
  • [5] Epoxyquinol B shows antiangiogenic and antitumor effects by inhibiting VEGFR2, EGFR, FGFR, and PDGFR
    Kamiyama, Hiroshi
    Kakeya, Hideaki
    Usui, Takeo
    Nishikawa, Kiyohiro
    Shoji, Mitsuru
    Hayashi, Yujiro
    Osada, Hiroyuki
    ONCOLOGY RESEARCH, 2008, 17 (01) : 11 - 21
  • [6] The Aurora A and Aurora B protein kinases - A single amino acid difference controls intrinsic activity and activation by TPX2
    Eyers, PA
    Churchill, MEA
    Maller, JL
    CELL CYCLE, 2005, 4 (06) : 784 - 789
  • [7] Immune-Mediated Antitumor Effect By VEGFR2 Selective Inhibitor For Gastric Cancer
    Yang, Ju
    Yan, Jing
    Shao, Jie
    Xu, Qiuping
    Meng, Fanyan
    Chen, Fangjun
    Ding, Naiqing
    Du, Shiyao
    Zhou, Shujuan
    Cai, Juan
    Wang, Qin
    Liu, Baorui
    ONCOTARGETS AND THERAPY, 2019, 12 : 9757 - 9765
  • [8] Antitumor activity of the aurora a selective kinase inhibitor, alisertib, against preclinical models of colorectal cancer
    Pitts, Todd M.
    Bradshaw-Pierce, Erica L.
    Bagby, Stacey M.
    Hyatt, Stephanie L.
    Selby, Heather M.
    Spreafico, Anna
    Tentler, John J.
    McPhillips, Kelly
    Klauck, Peter J.
    Capasso, Anna
    Diamond, Jennifer R.
    Davis, S. Lindsey
    Tan, Aik Choon
    Arcaroli, John J.
    Purkey, Alicia
    Messersmith, Wells A.
    Ecsedy, Jeffery A.
    Eckhardt, S. Gail
    ONCOTARGET, 2016, 7 (31) : 50290 - 50301
  • [9] Characterization and risk association of polymorphisms in Aurora kinases A, B and C with genetic susceptibility to gastric cancer development
    Aner Mesic
    Marija Rogar
    Petra Hudler
    Nurija Bilalovic
    Izet Eminovic
    Radovan Komel
    BMC Cancer, 19
  • [10] Characterization and risk association of polymorphisms in Aurora kinases A, B and C with genetic susceptibility to gastric cancer development
    Mesic, Aner
    Rogar, Marija
    Hudler, Petra
    Bilalovic, Nurija
    Eminovic, Izet
    Komel, Radovan
    BMC CANCER, 2019, 19 (01)
12345